- Home
- Companies
- usa california
- biomark
Show results for
Refine by
Biomark Suppliers In Usa California
70 companies found
Premium
based inFramingham, MASSACHUSETTS (USA)
SCIEX empowers you to solve the most impactful analytical challenges in quantitation and characterization in environmental testing. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field ...
based inNew York City, NEW YORK (USA)
AiCure is an AI and advanced data analytics company that monitors patient behavior and enables remote patient engagement in clinical trials. AiCure delivers patient insights to improve clinical trials. As the only company to provide a holistic view ...
AiCure Patient Connect is a suite of HIPAA and GDPR-compliant tools built within a mobile application to improve patient engagement, improve the relationship between the site and the patient, and achieve a deeper understanding of individual and ...
based inBrea, CALIFORNIA (USA)
A global leader in clinical diagnostics, Beckman Coulter Diagnostics has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One ...
The benchtop system includes the same automated capabilities and industry-leading 93% first-pass yield of our full-featured DxH 900 hematology analyzer,1 as well as support for the Early Sepsis Indicator (ESId) hematology biomarker ...
based inThousand Oaks, CALIFORNIA (USA)
Amgen is one of the world™s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen is committed to ...
based inPhiladelphia, PENNSYLVANIA (USA)
With extensive experience optimising processes for analytical, production and R&D laboratories across multiple industries and regulatory environments, we provide consistent, quality informatics solutions. We operate on a truly global basis, serving ...
Expand your research to cover 2M to 130M sequencing reads per run with this scalable platform. The Ion GeneStudio S5 systems are designed to enable a broad range of targeted next-generation sequencing (NGS) applications with speed and scalability. ...
based inSan Diego, CALIFORNIA (USA)
Invivoscribe is a global leader in molecular diagnostics, providing a comprehensive range of standardized, CE-marked in vitro diagnostic products and companion diagnostics for hematology-oncology. The company's offerings include research use only ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), ...
based inAlameda, CALIFORNIA (USA)
Fluxion delivers advanced solutions that transform complex cell-based and cell-free assays. Leading labs across the globe rely on Fluxion's instruments, kits, and lab services to research novel biology, accelerate drug discovery, and tailor ...
based inHayward, CALIFORNIA (USA)
Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays through innovation. Our signature technology platform is a proprietary polymer-based detection system. Based on this technology we have developed a series of highly ...
Use the Novodiax polymerized horseradish peroxidase (polyHRP) signal amplification technology (ihcDirect) and conjugate it directly to your humanized antibody-of-choice to enable rapid, sensitive IHC testing. Jumpstart your early humanized ...
based inSanta Clara, CALIFORNIA (USA)
For more than 40 years, Agilent Technologies has been the leading provider of solutions for the detection, identification, and characterization of chemical and biological compounds. From environmental testing to semiconductor manufacturing, ...
based inPalo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
AmpliMark is the foundational technology behind Lucence’s liquid biopsy tests. AmpliMark uses unique molecular barcodes in this error-correction technology. It is designed to improve detection of multiple mutation types like single nucleotide ...
based inSan Jose, CALIFORNIA (USA)
OptraSCAN’s intelligent digital pathology solutions equip pathologists with high-performing hardware and software to be more efficient, accurate, and consistent. OptraSCAN® is eliminating the barriers to adopting digital pathology no matter the size ...
OS-Ultra is a high-speed whole slide digital pathology scanner that scans tissues/cells of size 15×15 mm area at 40x equivalent in less than 60 seconds. OS-Ultra features a unique no-touch slide loading mechanism to diminish workflow errors ...
based inSan Diego, CALIFORNIA (USA)
Lynx Biosciences, Inc. (LynxBio) is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates ...
based inBrea, CALIFORNIA (USA)
We are pleased to announce the exclusive commercialization and sale of KinesisDx product lines to Krishgen Biosystems, India for worldwide usage effective July 11, 2019. This is in line with our philosophy to partner with forward looking companies ...
based inFoster City, CALIFORNIA (USA)
PointCross Life Sciences is a wholly-owned subsidiary of PointCross Inc. We are a global technology company providing the life sciences industry with solutions in big data analytics, management, visualization, and warehousing. Our offerings reduce ...
A format agnostic solution for harmonization across clinical, molecular biomarker, nonclinical and preclinical data for searchable cross study ...
based inVista, CALIFORNIA (USA)
Exagen is dedicated to transforming the care continuum for patients suffering from debilitating chronic autoimmune diseases. Our portfolio of innovative products enable timely differential diagnosis, prognosis, management, and optimization of ...
AVISE CTD is the only diagnostic test powered by patented Cell-Bound Complement Activation Products (CB-CAPs), stable biomarkers of complement activation, to help physicians better assess patients with suspected ...
based inPalo Alto, CALIFORNIA (USA)
Nirmidas Biotech was founded in September of 2013. We are a member of the Janssen Labs (JLABS) and QB3 programs, the Stanford StartX Med Program, and the MIT Industrial Liaison Program (MIT ILP). We are also a StartX Med COVID-19 Task Force Company ...
MidaScan-IR is a dual channel (700 nm and 800 nm) near-infrared (NIR) confocal microscope scanner for imaging tissues, cells, and microarrays on standard glass or plasmonic ...
based inHayward, CALIFORNIA (USA)
BioAssay Systems develops and markets innovative and high-throughput assay solutions to satisfy the ever increasing demands of the life sciences industry. The founders of BioAssay Systems have over 50 years of extensive experience in modern drug ...
based inSunnyvale, CALIFORNIA (USA)
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers. JSR ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
Idiopathic pulmonary fibrosis [IPF] is a form of progressive pulmonary fibrosis, or abnormal scarring of the lungs. As the disease progresses, the increased scarring leads to decreasing transfer of oxygen into the bloodstream, and ultimately, ...
